Related Experiment Video

Updated: Aug 14, 2026

Spatio-Temporal Manipulation of Small GTPase Activity at Subcellular Level and on Timescale of Seconds in Living Cells
10:27

Spatio-Temporal Manipulation of Small GTPase Activity at Subcellular Level and on Timescale of Seconds in Living Cells

Published on: March 9, 2012

Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling

Ken Inoki1, Yong Li, Tian Xu

  • 1Department of Biological Chemistry, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA.

Genes & Development
|July 19, 2003
PubMed

Insights

Tuberous sclerosis complex (TSC) involves mutations in TSC1 or TSC2. This study reveals TSC2 acts as a GTPase-activating protein for Rheb, a key regulator of cell growth via mTOR signaling.

Area of Science:

  • Molecular biology
  • Genetics
  • Cell signaling

Background:

  • Tuberous sclerosis complex (TSC) is a genetic disorder linked to mutations in TSC1 or TSC2 genes.
  • The TSC1/TSC2 complex normally inhibits the phosphorylation of S6K and 4EBP1, processes likely involving mTOR.
  • The precise mechanism by which TSC1/TSC2 regulates these downstream targets is not fully understood.

Purpose of the Study:

  • To elucidate the molecular mechanism by which the TSC1/TSC2 complex regulates mTOR signaling.
  • To identify the direct interaction partners and functions of TSC2 in the context of cell growth regulation.

Main Methods:

  • Investigated the GTPase activity of TSC2 towards Ras family GTPases.
  • Utilized biochemical assays to assess the effect of Rheb on S6K and 4EBP1 phosphorylation.
  • Employed rapamycin and dominant-negative mTOR to study the Rheb-mediated signaling pathway.

Main Results:

  • Demonstrated that TSC2 functions as a GTPase-activating protein (GAP) specifically for Rheb.
  • Showed that Rheb directly stimulates the phosphorylation of S6K and 4EBP1.
  • Confirmed that Rheb's activity is sensitive to rapamycin and dominant-negative mTOR, indicating its role in the mTOR pathway.
  • Established that Rheb acts downstream of TSC1/TSC2 and upstream of mTOR, linking these components in a regulatory cascade.

Conclusions:

  • TSC2's function as a Rheb-GAP is a critical step in the TSC pathway.
  • Rheb is an essential mediator connecting TSC1/TSC2 and mTOR signaling.
  • This pathway regulates cell growth in response to nutrient and energy availability.

More Related Videos

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Development and Application of Rapamycin-regulated Tyrosine Phosphatases06:56

Development and Application of Rapamycin-regulated Tyrosine Phosphatases

Published on: September 6, 2024

Related Concept Videos

Rab Proteins01:14

Rab Proteins

Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...